news
Largest psoriasis meta-analysis to date yields new genetic clues
1-2% of the US population have psoriasis, an immune-mediated disease that causes red, patchy and scaly marks on the skin.
List view / Grid view
Psoriasis
news
Anti-inflammatory drugs could treat symptoms of depression
18 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Anti-inflammatory drugs, like those used to treat rheumatoid arthritis and psoriasis could in future be used to treat some cases of depression...
news
Researchers identify a key molecule in psoriasis development
4 October 2016 | By Niamh Louise Marriott, Digital Content Producer
To go further in the TREX2 role in homeostasis and skin pathogenesis, the researchers wanted to see the role of this nuclease on psoriasis...
news
Possible new target for psoriasis identified
13 June 2016 | By Victoria White, Digital Content Producer
A small protein in the skin called Rac1 appears to link well-known environmental triggers of the disease with a genetic predisposition to the condition...
news
Research opens new psoriasis treatment strategies
25 April 2016 | By Victoria White, Digital Content Producer
A VIB/UGent research team reveals the molecular signalling mechanism by which mutations in CARD14 lead to increased inflammation in patients with psoriasis...
news
Domainex granted US and EU patents for its lead programme, targeting IKK epsilon and TBK1
11 May 2015 | By Victoria White
US and EU Patent Offices have granted Domainex patents for the first generation of inhibitor compounds in its lead programme targeting IKK epsilon and TBK1.
